Study of Aripiprazole in Patients With Acute Bipolar Mania

• Status: Completed
• Trial end date: 2007-01-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this research study is to confirm the safety and effectiveness of aripiprazole therapy over 12 weeks in subjects with bipolar disorder experiencing symptoms of mania.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
• Collaborator: Otsuka America Pharmaceutical
• Treatments: Aripiprazole; Haloperidol; Haloperidol decanoate

Criteria

Inclusion Criteria:

• Subjects with Bipolar I Disorder and a diagnosis of acute mania will be considered for this study.